home · filing · 0001493152-21-022552
8-K
filed September 13, 2021, 7:59 PM ET
ticker LFMD
CIK 0000948320
leadership
confidence high
sentiment neutral
materiality 0.50
LifeMD appoints Naveen Bhatia to board as Happy Walters resigns; Bhatia gets 8,000 RSUs and 100,000 options
LifeMD, Inc.
Happy Walters resigned from LifeMD board on September 8, 2021.
Naveen Bhatia appointed to board; he is a former Senior Director at Blackstone Tactical Opportunities Group.
Bhatia receives one-time grant of 8,000 RSUs vesting quarterly beginning September 30, 2021.
Bhatia also enters one-year consulting agreement: option to purchase 100,000 shares at $7.07 per share.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Naveen Bhatia
Director
Effective 2021-09-08
Filed September 13, 2021, 7:59 PM ET
On September 8, 2021, the Company appointed Naveen Bhatia as a member of the Board.
Departed
Happy Walters
Director
Effective 2021-09-08
Successor Naveen Bhatia
Filed September 13, 2021, 7:59 PM ET
On September 8, 2021, Happy Walters resigned from the board of directors (the “Board”) of LifeMD, Inc. (the “Company”).
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Naveen Bhatia was appointed as Director at LifeMD, Inc..
Action appointed
Role Director
Exact text from the filing
On September 8, 2021, the Company appointed Naveen Bhatia as a member of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Happy Walters resigned as Director at LifeMD, Inc..
Action resigned
Role Director
Exact text from the filing
On September 8, 2021, Happy Walters resigned from the board of directors (the “Board”) of LifeMD, Inc. (the “Company”).
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-21-022552
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.